News
The University of Kentucky Gill Heart and Vascular Institute is now accepting nominations for the 2020 Gill Awards. This year’s awards include the Early Career Award and the Outstanding Contributions to Cardiovascular Research. Nominations including self-nominations will be accepted until January 3, 2020. Award eligibility details along with the nomination form can be accessed by clicking here.
University of Kentucky Professor of Pharmacology and Nutritional Sciences Nancy Webb, Ph.D., has been honored by the American Heart Association with the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Distinguished Achievement Award.
The ATVB Council engages scientists and clinicians working to improve the prevention, diagnosis and treatment of heart disease. This annual accolade recognizes a member who has made major contributions to the council and substantial professional contributions to the field.
A postdoctoral scholar position is available in the Saha Cardiovascular Research Center to study vascular physiology and cardiovascular disease in the lab of Dr. Scott Gordon, Ph.D. The Gordon lab focuses on the role of lipoproteins in vascular inflammation and atherosclerosis. Our highly translational research projects range from in vitro cell culture experiments, to in vivo animal studies, to human gene association studies. Responsibilities of the position include working with Dr.
The University of Kentucky Gill Heart and Vascular Institute is now accepting nominations for the 2020 Gill Awards. This year’s awards include the Early Career Award and the Outstanding Contributions to Cardiovascular Research. Nominations including self-nominations will be accepted until December 6, 2019. Award eligibility details along with the nomination form can be accessed by clicking here.
https://www.ncbi.nlm.nih.gov/pubmed/31477775?dopt=Abstract
The links below contain all of the material you need for 2019 University of Kentucky Cardiovascular Research Day.
Schedule of the Day
Abstract Book
Wifi Help
miR-146a Deficiency Accelerates Hepatic Inflammation Without Influencing Diet-induced Obesity in Mice
Aida Javidan1, Weihua Jiang1, Michihiro Okuyama1, Devi Thiagarajan1, Lihua Yang1, Jessica J. Moorleghen1, Latha Muniappan1 & Venkateswaran Subramanian1,2
1Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA. 2Department of Physiology, University of Kentucky, Lexington, KY, USA. Latha Muniappan is deceased.
Please Save the Date for the 2019 º£½Ç½ûÇø Cardiovascular Research Retreat, Friday, May 10th from 2:00-5:00 pm at the Boone Center. Lunch will be provided from 12:00-1:00 pm.
Abstract
Heparin-binding EGF-like growth factor (HB-EGF) is a representative EGF family member that interacts with EGFR under diverse stress environment. Previously, we reported that the HB-EGF-targeting using antisense oligonucleotide (ASO) effectively suppressed an aortic aneurysm in the vessel wall and circulatory lipid levels. In this study, we further examined the effects of the HB-EGF ASO administration on the development of hyperlipidemia-associated atherosclerosis using an atherogenic mouse model.
METHODS AND RESULTS:
The 5th Annual Healthy Hearts for Women Symposium will take place this Friday, February 1st. This year's symposium features four distinguished faculty from across the nation and Canada. The event begins at 8:30 am with registration and breakfast in Pavilion A Auditorium in the University of Kentucky Medical Center.